We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Myhealthchecked Plc | LSE:MHC | London | Ordinary Share | GB00BN7K5L93 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.50 | 10.50 | 10.00 | 9.50 | 10.00 | 4,417 | 08:00:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 22.31M | 1.52M | 0.0292 | 3.42 | 5.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/12/2023 12:34 | Dual My concern given that they keep running out of tests like the Covid 25pk is they are not able to cope with demand. How and why would you keep running out if the team is well equipped. Especially when you’re in the midst of a surge in new variants. Anyway let’s hope they have a plan and deliver at the end of the Month. However even a 100% rise won’t help most investors so it’s a real shame that confidence has be battered. Let’s hope news is leaked a faith restored so 2024 can be a positive year. Money is made taking risk whilst shares are low and when you have more cash than market capital I guess the risk is low. I expect a special dividend hopefully | tia01 | |
22/12/2023 09:01 | Tia do agree with your figures.Also, the market needs to realise Covid will be around for many more years. | dual | |
21/12/2023 16:29 | Last year’s update was 31st January however if they have had a positive 2nd half since June I strongly suspect it will be early January as they will want to get it out there. The bad news between January and June was anticipated however no one is anticipating the good news since. I for one expect us to definitely have between 7-8 million in the bank and despite only 2.5m turnover between January and June I’d strongly suspect the second half will take us up to to at least 10-11m turnover. 2600 store’s selling flowflex tests between Boots and Lloyds!. Online sales at Boots!. MHC selling new tests direct and a few on Amazon. It’s seriously well undervalued however the markets will need need positive news to fuel it. Amazing given how prudent the company has been in these times I would have hoped the markets would have re rated them. Any way anyone selling at these levels would be making a mistake but the buyers must be nervous. Why! When they have cash and products and no need to dilute. Could a special dividend be on the way. Could a larger competitor snap this up given how low the price is and cash position alone. Any way all have a blessed Christmas | tia01 | |
21/12/2023 15:07 | This share is operating like a share that’s been suspended!!! Absolutely no trades day by day. Let’s hope for a positive update soon. I’m sure Penny must aware what it’s doing to shareholders confidence and value. | tia01 | |
21/12/2023 08:51 | I expect an update mid Jan.And hope they will get a contract or two in the coming months.. | dual | |
20/12/2023 22:45 | I would have been happy to see the board dipping in to the shares and buying a few for Christmas to help celebrate 🍾 the year end. No shares traded of late and near year lows. Let’s hope they give us a positive surprise to celebrate with them | tia01 | |
20/12/2023 21:55 | Trading update on 31 Jan 23 last FY. | weatherman | |
20/12/2023 20:02 | A positive post on LinkedIn by MHC:________So very proud of this team for their 2024 readiness, as we celebrate the completion of 2023 and some great product launches and services! Superb efforts this year, and we are so ready to deliver some great work next year. Feeling really positive and excited about everything that we have ahead of us team! _______Expecting a good update and a positive outlook in the coming weeks. | dual | |
18/12/2023 20:21 | hxxps://www.amazon.c Dropped to 40k a month and on the way back up to 60k a month. So we are definitely experiencing another spike. Guessing things are definitely going well for MHC looking at sales on Boots site | tia01 | |
18/12/2023 11:40 | Four relatives have tested positive for covid in the last two weeks. Lots of mingling supporting the MHC bank balance. | columbarius | |
16/12/2023 17:31 | Mike Relax I just get frustrated just as most long term holders are. Let’s see how trading goes and hopefully something happens positive to get investors interested in buying in. The fact is no one is buying at virtually all time lows. Every one knows on paper and fact we have cash in the Bank the shares are cheap. However we also can see little share action which signals risk appetite not there at the moment. Many things could be done to encourage a better share price but in the end we have to be patient. Your correct you only get burnt when you sell but when you bought in at a much high price to support the journey and get as little updates as we do it definitely feels like we’ve been shafted. That said as an investor we all know the risks and hopefully MHC keep delivering and 2024 is the year of a comeback. | tia01 | |
16/12/2023 15:57 | Nobody has been burned Tia01, stop bring so dramatic, you are only burned if you sell at a loss. Re: valuation of the stock, one insight to how MHC as a HealthTech play might be valued: HealthTech M&A transactions HealthTech M&A transactions can vary significantly in terms of size, nature, and market conditions. The multiples, or valuation metrics, used in these transactions are typically based on factors such as revenue, earnings, or users/subscribers, and can differ based on the company's stage of development, growth prospects, market position, and other relevant factors. Revenue Multiples: One commonly used metric is the revenue multiple, which measures the value of a company relative to its revenue. In HealthTech, revenue multiples can range widely depending on factors such as the company's growth rate, profitability, and competitive landscape. In the past, revenue multiples for HealthTech companies have ranged from 1x to 10x or more, with some highly valued companies commanding even higher multiples. Earnings Multiples: Another metric used in M&A transactions is the earnings multiple, which compares a company's valuation to its earnings (e.g., EBITDA - Earnings Before Interest, Taxes, Depreciation, and Amortization). Earnings multiples for HealthTech companies can vary based on factors such as profitability, growth potential, and industry trends. The range of earnings multiples in the HealthTech sector has historically been broad, spanning from single-digit multiples to higher double-digit or triple-digit multiples for high-growth, high-margin companies. User/Subscriber Multiples: In some cases, HealthTech companies with user-focused business models, such as telemedicine or digital health platforms, may be valued based on the number of users or subscribers they have acquired. Valuations based on these metrics can vary significantly depending on the size of the user base, user engagement, revenue per user, and other factors. While there isn't a fixed average multiple for user/subscriber-base Why not hypothesise about the share value going forward (in the absense of hard data from the BoD) instead of going on about the lack of comms, sales updates, share buybacks? SPOILER ALERT: They have excellent stock options already, are debt free, are making sales and releasing new products - They don't need to buy shares themselves. The business is in a formidable, enviable position at this point in its history. Change the record, do you have any new discussion points relating to this stock you can raise? | mike2042 | |
14/12/2023 22:17 | The lack of news makes you want to clear the decks but then you look at fundamentals and actually see it’s in a healthy place. Problem for investors is without a doubt they would need 30p to even start to break even. Looks like a pump is needed but with no buying and no news confidence all but gone id say many changing the p to a d. It has everything to be a success story but the boards silence and embarrassing lack of share buying sends the wrong signal. Covid sales flying and I guess revenue equally but in the market sentiment is more valuable than anything now. Sentiment has switched towards indebted companies that will benefit from future rate cuts. I suspect our board ain’t putting their own money in but happy to extract large wages. They can’t even keep a line of 25pk lateral flow tests stocked and they are actually selling daily so how would they cope with pent up demand for new products. As an investor I just feel lucky we’ve got a decent cash flow and the board don’t need to come with a begging bowl. I doubt many investors will put more in because daily shares transactions are dismal and it just trickles lower without news. Totally disgraceful from our board who claims marketing experience and accounting professionalism. Maybe the accountant should advise the board to buy in. A Chairman who bought higher that has given up at these levels!. Who will show a little support. None of them for now it seems. Back at all time lows soon despite have more cash in the bank etc, more products etc just shows what happens when markets lose faith. Penny should look at her position and ask what’s happened to shareholders value when they receive free shares. Many been burned by the boards silence | tia01 | |
14/12/2023 21:06 | At some point innjanaury or Feb is my guess Tia. A pump n dump is our only hope. Divi might do the trick albeit very slowly. Buybacks won't to nothing to the sp | spacedust | |
14/12/2023 19:24 | December 31st I mean | tia01 | |
14/12/2023 17:15 | So if the financial year is ending January 31st when would we expect an update for the financial year from the board! | tia01 | |
14/12/2023 16:34 | Looking at share trades I guess everyone has given up and threw the towel. All seems like people have totally lost faith in this one. The board definitely don’t care about shareholders otherwise they would have done something to sure up the price. They will probably award themselves huge bonuses to dwindle cash down throw investors to the wall. The lack of info is disgraceful | tia01 | |
13/12/2023 17:28 | Sometimes you have to say given the lack of share trades that no matter what MHC does the market ain’t interested it the company! Many companies on the verge of collapse jumping 20-30% while we struggle to even trade a couple of grand shares a day. I’m actually beginning to wonder if a share buyback or dividend is the only thing that will attract positive attention. It’s clear they need a new approach to increasing share value as most investors probably lost two thirds of their investment in the share | tia01 | |
13/12/2023 00:05 | Interesting and worth a listen. | tia01 | |
07/12/2023 17:35 | Spacedust One day hopefully it joins the 70% club | tia01 | |
07/12/2023 09:00 | What's all the excitement about? Reading the posts did mhc go up by 70%? | spacedust | |
07/12/2023 08:02 | Is it time to protect our people! Testing is the only way | tia01 | |
06/12/2023 17:11 | Is it a false start or the real thing! You can never tell and by the time you’ve worked it out you’ve usually missed the boat or on the hand got spike up your jacksey lol. Nice to see a positive day though | tia01 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions